TNDM

19.17

2.12% -0.415

Dopo l'orario di chiusura: 19.16 -0.01 -0.05%

Tandem Diabetes Care Inc (TNDM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TNDM Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$19.59

Aprire:

$19.62

Volume 24 ore:

1.79M

Relative Volume:

0.94

Capitalizzazione di mercato:

$1.31B

Reddito:

$1.01B

Utile/perdita netta:

$-204.71M

Rapporto P/E:

-6.2461

EPS:

-3.0691

Flusso di cassa netto:

$-29.67M

1 W Prestazione:

-21.79%

1M Prestazione:

-24.23%

6M Prestazione:

+57.91%

1 anno Prestazione:

+0.05%

Intervallo 1D:

$18.89

$20.30

Intervallo di 1 settimana:

$18.89

$25.05

Portata 52W:

$9.98

$29.65

Tandem Diabetes Care Inc Stock (TNDM) Company Profile

Nome

Tandem Diabetes Care Inc

Settore

Healthcare (1114)

Industria

Medical Devices (143)

Telefono

858-366-6900

Indirizzo

12400 HIGH BLUFF DRIVE, San Diego, CA

Dipendente

2,500

Cinguettio

@tandemdiabetes

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

TNDM's Discussions on Twitter

Compare TNDM vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TNDM Tandem Diabetes Care Inc	19.17	1.34B	1.01B	-204.71M	-29.67M	-3.0691
ABT Abbott Laboratories	102.67	177.03B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	328.59	124.89B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	86.65	110.08B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	62.75	93.53B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	80.08	45.84B	6.07B	1.06B	1.34B	1.8063

Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-19	Aggiornamento	Truist	Hold → Buy
2026-03-17	Aggiornamento	Piper Sandler	Neutral → Overweight
2026-02-23	Aggiornamento	Lake Street	Hold → Buy
2026-02-20	Aggiornamento	BofA Securities	Underperform → Neutral
2026-01-27	Ripresa	TD Cowen	Buy
2025-12-16	Aggiornamento	Robert W. Baird	Neutral → Outperform
2025-10-21	Ripresa	Stifel	Hold
2025-09-08	Iniziato	Oppenheimer	Outperform
2025-08-12	Aggiornamento	Citigroup	Sell → Neutral
2025-08-07	Downgrade	Piper Sandler	Overweight → Neutral
2025-07-09	Downgrade	Citigroup	Neutral → Sell
2025-06-16	Iniziato	Truist	Hold
2025-04-10	Iniziato	Mizuho	Neutral
2025-03-05	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2025-03-04	Downgrade	Citigroup	Buy → Neutral
2025-03-03	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-02-28	Downgrade	Bernstein	Outperform → Mkt Perform
2024-12-02	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-11-06	Iniziato	Bernstein	Outperform
2024-10-04	Iniziato	Goldman	Neutral
2024-10-02	Iniziato	RBC Capital Mkts	Outperform
2024-08-22	Iniziato	Morgan Stanley	Equal-Weight
2024-08-08	Iniziato	Canaccord Genuity	Buy
2024-05-30	Iniziato	Redburn Atlantic	Buy
2024-05-22	Aggiornamento	Citigroup	Neutral → Buy
2024-04-29	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-04-25	Aggiornamento	Leerink Partners	Market Perform → Outperform
2024-03-26	Aggiornamento	Stifel	Hold → Buy
2023-08-04	Downgrade	Citigroup	Buy → Neutral
2023-05-05	Downgrade	BofA Securities	Neutral → Underperform
2023-04-24	Downgrade	Raymond James	Outperform → Mkt Perform
2023-03-29	Iniziato	UBS	Neutral
2023-01-26	Iniziato	Wolfe Research	Peer Perform
2022-11-15	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2022-10-18	Iniziato	Barclays	Overweight
2022-10-12	Iniziato	Jefferies	Buy
2022-08-09	Downgrade	Wells Fargo	Overweight → Underweight
2022-03-02	Ripresa	BofA Securities	Neutral
2022-01-19	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2021-07-21	Ripresa	Cowen	Outperform
2021-05-25	Iniziato	Barclays	Underweight
2020-12-15	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-08-20	Iniziato	Wells Fargo	Overweight
2020-07-31	Aggiornamento	Guggenheim	Neutral → Buy
2020-07-06	Aggiornamento	Citigroup	Neutral → Buy
2020-06-18	Reiterato	Raymond James	Outperform
2020-04-24	Downgrade	SVB Leerink	Outperform → Mkt Perform
2020-03-23	Downgrade	Guggenheim	Buy → Neutral
2020-03-05	Iniziato	Citigroup	Neutral
2020-02-06	Iniziato	Raymond James	Outperform
2020-02-04	Downgrade	Robert W. Baird	Outperform → Neutral
2019-10-18	Iniziato	Guggenheim	Buy
2019-10-04	Aggiornamento	UBS	Neutral → Buy
2019-05-17	Reiterato	BofA/Merrill	Neutral
2019-05-13	Iniziato	SVB Leerink	Outperform
2019-03-08	Iniziato	BMO Capital Markets	Outperform
2019-03-05	Reiterato	BofA/Merrill	Neutral
2019-02-27	Reiterato	Lake Street	Buy
2018-11-21	Aggiornamento	Robert W. Baird	Neutral → Outperform
2018-09-26	Reiterato	Dougherty & Company	Buy
2018-09-26	Reiterato	Piper Jaffray	Overweight

Mostra tutto

Tandem Diabetes Care Inc Borsa (TNDM) Ultime notizie

Mar 30, 2026

Tandem Diabetes Care Stock Hits Day Low Amid Price Pressure at $20.93 - Markets Mojo

Mar 30, 2026

Tandem Diabetes Care (TNDM) reports Q4 earnings: What key metrics have to say - MSN

Mar 30, 2026

Mar 29, 2026

Stock List: Research Stocks from Around the World - gurufocus.com

Mar 29, 2026

Tandem Diabetes and Roche Reach a Patent Settlement - MSN

Mar 29, 2026

Mar 27, 2026

Board asks shareholders to approve 3.26M-share increase; TNDM files proxy (TNDM) - Stock Titan

Mar 27, 2026

Tandem Diabetes Care (NASDAQ:TNDM) Trading Down 6.6%Time to Sell? - MarketBeat

Mar 27, 2026

Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know - TradingView

Mar 27, 2026

[SCHEDULE 13G/A] TANDEM DIABETES CARE INC Amended Passive Investment Disclosure - Stock Titan

Mar 27, 2026

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire

Mar 27, 2026

Mizuho maintains Tandem Diabetes Care (TNDM) neutral recommendation - MSN

Mar 27, 2026

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Mar 27, 2026

Mar 26, 2026

Assenagon Asset Management S.A. Invests $26.99 Million in Tandem Diabetes Care, Inc. $TNDM - MarketBeat

Mar 26, 2026

Mar 25, 2026

Strength seen in Tandem Diabetes Care (TNDM): Can its 9.1% jump turn into more strength? - msn.com

Mar 25, 2026

Mar 23, 2026